Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Stock Transactions
SEC Form 4 Filing
Executive VP and CFO of H.B. Fuller, John J. Corkrean, reports the acquisition of phantom units and details existing stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing includes the acquisition of 102.99 phantom units, which convert to common stock on a 1-for-1 basis.
- The report also lists various employee stock options with different exercise prices and vesting schedules.
- Additionally, the filing details restricted stock units that vest over three years and convert to common stock on a 1-for-1 basis.
- The report includes a total of 47,187 shares of common stock beneficially owned by Mr. Corkrean.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of executive stock transactions, which is generally neutral but positive in that it shows alignment of interests. There are no negative implications.
Positives
- The acquisition of phantom units indicates continued alignment of executive interests with shareholder value.
- The vesting schedules of stock options and restricted stock units incentivize long-term performance.
Industry Context
This filing is a routine disclosure of executive stock transactions, common in publicly traded companies. It provides transparency into the compensation structure and alignment of interests between management and shareholders.
Comparison to Industry Standards
- The use of stock options and restricted stock units is a standard practice for executive compensation in publicly traded companies like H.B. Fuller.
- The vesting schedules and exercise prices are typical for incentivizing long-term performance and retention.
- Companies like 3M, Sherwin-Williams, and PPG Industries also use similar equity-based compensation plans for their executives.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding executive compensation.
- The vesting schedules of stock options and restricted stock units align executive interests with long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for an employee stock option with an exercise price of $43.48. |
| 01/26/2018 | Date of grant for an employee stock option with an exercise price of $50.1. |
| 01/25/2019 | Date of grant for an employee stock option with an exercise price of $53.57. |
| 01/24/2020 | Date of grant for an employee stock option with an exercise price of $45.05. |
| 01/24/2021 | Date of grant for an employee stock option with an exercise price of $48.35. |
| 01/24/2023 | Date of grant for an employee stock option with an exercise price of $72.94 and restricted stock units. |
| 01/24/2024 | Date of grant for an employee stock option with an exercise price of $68.17 and restricted stock units. |
| 01/26/2025 | Date of grant for an employee stock option with an exercise price of $77.72 and restricted stock units. |
| 11/22/2024 | Date of the reported transaction involving the acquisition of phantom units. |
| 11/25/2024 | Date of the signature of the report. |
Keywords
Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, Phantom Units, Executive Compensation, H.B. Fuller, FUL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.